| VVOS | 8-K | bullish | 5/10 | Vivos Therapeutics announced the issuance of US Patent No. 12,697,190, a continuation patent that broadens protection fo | Aug 11, 2026 |
| WAFD | 8-K | neutral | 2/10 | WaFd, Inc. declared a routine quarterly cash dividend on its 4.875% Series A Non-Cumulative Perpetual Preferred Stock (W | Aug 11, 2026 |
| GPI | 8-K, PRESS-RELEASE | neutral | 2/10 | Group 1 Automotive filed an 8-K covering three routine items: (1) the appointment of former Ulta Beauty CEO Dave Kimbell | Aug 11, 2026 |
| IMNN | 8-K | neutral | 3/10 | Imunon filed an 8-K disclosing that its Compensation Committee approved stock-for-salary election programs for three top | Aug 11, 2026 |
| AVXL | 8-K | neutral | 4/10 | Anavex filed definitive proxy materials for its September 24, 2026 annual meeting, urging shareholders to vote for its s | Aug 11, 2026 |
| BGS | 8-K | neutral | 4/10 | B&G Foods CEO Casey Keller retired effective August 7, 2026, with a retirement package including $2.45M salary continuat | Aug 11, 2026 |
| RGP | 8-K | neutral | 2/10 | RGP announced a quarterly cash dividend of $0.07 per share, payable October 1, 2026 to holders of record September 3, 20 | Aug 11, 2026 |
| AARD | 8-K | bearish | 8/10 | Aardvark Therapeutics reported Q2 2026 financial results with a net loss of $14.4M (EPS -$0.66), essentially flat vs the | Aug 11, 2026 |
| MLCI | 8-K | mixed | 5/10 | Mount Logan Capital reported Q2 2026 results with Segment Income improving to $4.3M, up $2.1M YoY, driven by a strong tu | Aug 11, 2026 |
| FOCL | 8-K | bullish | 7/10 | FocalTherics (formerly EDAP TMS) reported preliminary Q2 2026 HIFU revenue of $12.7M-$13.2M (+34-39% YoY), a record quar | Aug 11, 2026 |
| UAMY | 8-K | bearish | 7/10 | UAMY reported Q2 2026 revenue of $7.9M (down 25% YoY from $10.5M) and a net income of $0.1M, but an operating loss of $7 | Aug 11, 2026 |
| KYTX | 8-K | bullish | 6/10 | Kyverna reported Q2 2026 net loss of $0.63 per share, narrower than the $0.67 consensus, with cash burn continuing. The | Aug 11, 2026 |
| KPLT | 8-K | bearish | 7/10 | Katapult Holdings' subsidiary Katapult Intermediate Holdings, LLC entered into a $200M term loan agreement ($145M initia | Aug 11, 2026 |
| EML | 8-K | bearish | 6/10 | Eastern Co. reported Q2 2026 GAAP EPS of $0.94, inflated by a $6.5M one-time bargain purchase gain from the Sungear/Crow | Aug 11, 2026 |
| PXLW | 8-K | bearish | 6/10 | Pixelworks reported Q2 2026 revenue of $64,000, a 60% decline YoY from $159,000, and a GAAP net loss from continuing ope | Aug 11, 2026 |
| ENGN | 8-K | neutral | 3/10 | enGene Therapeutics hosted a virtual KOL event on August 11, 2026, presenting market research on the NMIBC BCG-unrespons | Aug 11, 2026 |
| THRY | 8-K | neutral | 3/10 | Thryv Holdings filed an 8-K to terminate its 2026 annual Short-Term Incentive Plan and replace it with a H2 2026 Bridge | Aug 11, 2026 |
| APGE | 8-K | bullish | 7/10 | Apogee Therapeutics stockholders voted overwhelmingly to approve the $135.11/share all-cash acquisition by AbbVie, with | Aug 11, 2026 |
| WKSP | 8-K | bullish | 6/10 | Worksport reported Q2 2026 record revenue of $5.23M (+27.4% YoY, +57.9% QoQ), gross profit of $1.65M (+52.5% YoY, +93.2% | Aug 11, 2026 |
| ANTX | 8-K | neutral | 4/10 | AN2 Therapeutics reported Q2 2026 net loss of $8.2M ($0.18/share) vs $6.5M ($0.21/share) in Q2 2025, with net loss per s | Aug 11, 2026 |
| VELO | 8-K | bullish | 7/10 | Velo3D reported Q2 2026 revenue of $20.7M, up 52.3% YoY, and raised its full-year 2026 revenue guidance to $65M-$75M fro | Aug 11, 2026 |
| FLD | 8-K | bearish | 6/10 | Fold Holdings reported Q2 2026 revenue of $6.1M, a 25.5% YoY decline from $8.2M, with a GAAP net loss of $9.7M (EPS -$0. | Aug 11, 2026 |
| SND | 8-K | bullish | 7/10 | Smart Sand reported a record-breaking Q2 2026 with revenue surging 34% YoY to $115.1M and net income swinging to $10.2M | Aug 11, 2026 |
| BRK-B | 8-K | bullish | 6/10 | Berkshire Hathaway reported Q2 2026 operating earnings of $12.983 billion, up 16.4% from $11.160 billion in Q2 2025, dri | Aug 11, 2026 |
| TXMD | 8-K | bearish | 5/10 | TherapeuticsMD reported Q2 2026 results showing declining license revenue ($869K vs $952K YoY) and net income ($164K vs | Aug 11, 2026 |
| FFLO | 8-K | bearish | 7/10 | Free Flow USA, Inc. (FFLO) filed an 8-K reporting that its independent auditor, BCRG Group, Inc., resigned on August 5, | Aug 11, 2026 |
| FJDIU | 8-K | neutral | 4/10 | ARC Group Securities Acquisition I (FJDIU) completed its IPO on August 5, 2026, raising $105 million in gross proceeds b | Aug 11, 2026 |
| NHC | 8-K | neutral | 3/10 | NHC announced a quarterly common dividend of $0.67 per share, payable on October 30, 2026 to shareholders of record on S | Aug 11, 2026 |
| NHC | 8-K | bullish | 6/10 | NHC reported Q2 2026 net operating revenues of $408.0M (+8.8% YoY), driven by the June 1 acquisition of five skilled nur | Aug 11, 2026 |
| MYPS | 8-K | bearish | 6/10 | PLAYSTUDIOS reported Q2 2026 revenue of $55.0M, down 7.3% YoY from $59.3M, and a net loss of $13.3M (loss per share -$0. | Aug 11, 2026 |